{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-088238","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.910893+00:00","generated_at":"2026-05-17T07:38:43.794840+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bicycle Therapeutics appoints Roger Dansey and Hervé Hoppenot to Board of Directors","bullets":["Roger Dansey, M.D. (ex-Pfizer/Seagen) and Hervé Hoppenot (ex-Incyte/Novartis) joined the board effective Sep 8, 2025.","Board expanded from 8 to 10 members; Dr. Dansey serves as Class III director, Mr. Hoppenot as Class I director.","Both are independent; Dr. Dansey will serve on Scientific and Nominating/Governance committees, Mr. Hoppenot on Audit and Compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-088238","json":"https://secwatch.observer/filing/0001104659-25-088238.json","markdown":"https://secwatch.observer/filing/0001104659-25-088238.md","text":"https://secwatch.observer/filing/0001104659-25-088238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/0001104659-25-088238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/tm2525491d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:38:43.794840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}